QI
KRSA

QS Investors’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

QS Investors’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$453K Hold
829
– – 0.01% 777
2021
Q1 		$324K Buy
829
+96
+13% +$7.21K ﹤0.01% 958
2020
Q4 		$314K Buy
+733
New +$50K ﹤0.01% 973

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

QS Investors's KRSA Position: Q2 2021 in Review

QS Investors held its Korsana Biosciences, Inc. Common Stock (KRSA) position steady in Q2 2021 at 829 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #777.

QS Investors first reported a position in KRSA in Q4 2020 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold KRSA as of Q2 2021.

  • QS Investors held 829 shares of Korsana Biosciences, Inc. Common Stock worth $453K as of Q2 2021.
  • QS Investors left its Korsana Biosciences, Inc. Common Stock share count unchanged in Q2 2021.
  • Korsana Biosciences, Inc. Common Stock made up 0.01% of QS Investors's portfolio in Q2 2021, its #777 holding.
  • QS Investors first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2020 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.